In appreciation of the leadership and stewardship of Drs Thomas J. Garite and Moon H. Kim









Ingrid E. Nygaard





Roberto Romero
Drs Thomas J. Garite and Moon H. Kim, Editors-in-Chief of the American Journal of Obstetrics and Gynecology (AJOG) for the last 10 years (2003-2013), have led the Journal to continue to be a valuable resource for women’s health, as it has been for nearly 150 years. During their tenure, AJOG implemented an innovative business model and format. To ensure that all US obstetrician-gynecologists have access to AJOG’s valuable content, the print version of the journal has been provided at no charge. The online version became the “official” version of the Journal, and short summaries were provided in print so that information would be presented in an efficient manner to busy clinicians.


AJOG continues to be a premier academic journal in obstetrics and gynecology. Under the leadership of Drs Garite and Kim, the impact factor of the Journal increased and the submission to review and publication times shortened dramatically; the circulation of AJOG is approximately 45,000. Innovative new series have been launched successfully including the widely regarded Patient Safety , the creation of “Reports of Major Impact,” an “Imaging” section in Obstetrics and in Gynecology, and Journal Club, among others. Drs Garite and Kim have also contributed by implementing the policy of AJOG to protect the integrity of the medical science that is published in the Journal and by sharing their perspectives in the form of editorials, perspectives on topical issues, and their own important original work.


With AJOG’s publisher, Elsevier, Drs Garite and Kim have spearheaded many changes in the delivery of information to serve readers with an updated website and a mobile app for the Journal. Dr Garite has been the primary Editor-in-Chief for Obstetrics, and Dr Kim for Gynecology. However, they both refined the overall mission, format, and character of the Journal.


On behalf of the Editors, readers, authors, and staff, we are grateful to Drs Garite and Kim for their many contributions to AJOG and to women’s health. We consider ourselves privileged to serve as Editors-in-Chief of this prestigious Journal and will strive to steward AJOG in a manner that serves authors, readers, and patients—this will be done by being responsive to the emerging changes of the information age.


References



  1. 1. Garite T.J., and Kim M.H.: Farewell editorial. Am J Obstet Gynecol 2013; 209: pp. 501

  2. 2. Garite T.J.: Patient safety series. Am J Obstet Gynecol 2011; 204: pp. 1

  3. 3. Garite T.J.: Reports of major impact. Am J Obstet Gynecol 2010; 202: pp. 97

  4. 4. Towers C.V., Freeman R.K., Nageotte M.P., Garite T.J., Lewis D.F., and Quilligan E.J.: The case for amniocentesis for fetal lung maturity in late-preterm and early-term gestations. Am J Obstet Gynecol 2013; undefined:

  5. 5. Garite T.J.: The search for an adequate back-up test for intrapartum fetal heart rate monitoring. Am J Obstet Gynecol 2013; 208: pp. 163-164

  6. 6. Romero R., and Garite T.J.: Twenty percent of very preterm neonates (23-32 weeks of gestation) are born with bacteremia caused by genital . Am J Obstet Gynecol 2008; 198: pp. 1-3

  7. 7. Romero R., and Garite T.J.: Unexpected results of an important trial of vitamins C and E administration to prevent preeclampsia. Am J Obstet Gynecol 2006; 194: pp. 1213-1214

  8. 8. Clark S.L., Nageotte M.P., Garite T.J., et al: Intrapartum management of category II fetal heart rate tracings: towards standardization of care. Am J Obstet Gynecol 2013; 209: pp. 89-97

  9. 9. Olson R., Garite T.J., Fishman A., and Andress I.F.: Obstetrician/gynecologist hospitalists: can we improve safety and outcomes for patients and hospitals and improve lifestyle for physicians? Am J Obstet Gynecol 2012; 207: pp. 81-86

  10. 10. Clark S.L., Simpson K.R., Knox G.E., and Garite T.J.: Oxytocin: new perspectives on an old drug. Am J Obstet Gynecol 2009; 200: pp. 35.e1-35.e6

  11. 11. Weinstein L., and Garite T.J.: On call for obstetrics: time for a change. Am J Obstet Gynecol 2007; 196: pp. 3

  12. 12. Lu M.C., Lin Y.G., Prietto N.M., and Garite T.J.: Elimination of public funding of prenatal care for undocumented immigrants in California: a cost/benefit analysis. Am J Obstet Gynecol 2000; 182: pp. 233-239

  13. 13. Garite T.J., Kurtzman J., Maurel K., and Clark R.: Impact of a ‘rescue course’ of antenatal corticosteroids: a multicenter randomized placebo-controlled trial. Am J Obstet Gynecol 2009; 200: pp. 248.e1-248.e9

  14. 14. Shrivastava V.K., Garite T.J., Jenkins S.M., et al: A randomized, double-blinded, controlled trial comparing parenteral normal saline with and without dextrose on the course of labor in nulliparas. Am J Obstet Gynecol 2009; 200: pp. 379.e1-379.e6

  15. 15. Stafford I.P., Garite T.J., Dildy G.A., et al: A comparison of speculum and nonspeculum collection of cervicovaginal specimens for fetal fibronectin testing. Am J Obstet Gynecol 2008; 199: pp. 131.e1-131.e4

  16. 16. Haydon M.L., Gorenberg D.M., Nageotte M.P., et al: The effect of maternal oxygen administration on fetal pulse oximetry during labor in fetuses with nonreassuring fetal heart rate patterns. Am J Obstet Gynecol 2006; 195: pp. 735-738

  17. 17. Heyborne K.D., Porreco R.P., Garite T.J., Phair K., and Abril D.: Improved perinatal survival of monoamniotic twins with intensive inpatient monitoring. Am J Obstet Gynecol 2005; 192: pp. 96-101

  18. 18. Wadhwa P.D., Garite T.J., Porto M., et al: Placental corticotropin-releasing hormone (CRH), spontaneous preterm birth, and fetal growth restriction: a prospective investigation. Am J Obstet Gynecol 2004; 191: pp. 1063-1069

  19. 19. Garite T.J., Clark R., and Thorp J.A.: Intrauterine growth restriction increases morbidity and mortality among premature neonates. Am J Obstet Gynecol 2004; 191: pp. 481-487

  20. 20. Porreco R.P., Boehm F.H., Dildy G.A., et al: Dystocia in nulliparous patients monitored with fetal pulse oximetry. Am J Obstet Gynecol 2004; 190: pp. 113-117

  21. 21. Chung J.H., Boscardin W.J., Garite T.J., Lagrew D.C., and Porto M.: Ethnic differences in birth weight by gestational age: at least a partial explanation for the Hispanic epidemiologic paradox? Am J Obstet Gynecol 2003; 189: pp. 1058-1062

  22. 22. Gorenberg D.M., Pattillo C., Hendi P., Rumney P.J., and Garite T.J.: Fetal pulse oximetry: correlation between oxygen desaturation, duration, and frequency and neonatal outcomes. Am J Obstet Gynecol 2003; 189: pp. 136-138

  23. 23. Major C.A., Towers C.V., Lewis D.F., and Garite T.J.: Expectant management of preterm premature rupture of membranes complicated by active recurrent genital herpes. Am J Obstet Gynecol 2003; 188: pp. 1551-1555

  24. 24. Garite T.J., Weeks J., Peters-Phair K., Pattillo C., and Brewster W.R.: A randomized controlled trial of the effect of increased intravenous hydration on the course of labor in nulliparous women. Am J Obstet Gynecol 2000; 183: pp. 1544-1548

  25. 25. Garite T.J., Dildy G.A., McNamara H., et al: A multicenter controlled trial of fetal pulse oximetry in the intrapartum management of nonreassuring fetal heart rate patterns. Am J Obstet Gynecol 2000; 183: pp. 1049-1058

  26. 26. Lewis D.F., Adair C.D., Weeks J.W., Barrilleaux P.S., Edwards M.S., and Garite T.J.: A randomized clinical trial of daily nonstress testing versus biophysical profile in the management of preterm premature rupture of membranes. Am J Obstet Gynecol 1999; 181: pp. 1495-1499

  27. 27. Lovett S.M., Weiss J.D., Diogo M.J., Williams P.T., and Garite T.J.: A prospective, double-blind, randomized, controlled clinical trial of ampicillin-sulbactam for preterm premature rupture of membranes in women receiving antenatal corticosteroid therapy. Am J Obstet Gynecol 1997; 176: pp. 1030-1038

  28. 28. Lewis D.F., Towers C.V., Major C.A., et al: Use of Amniostat-FLM in detecting the presence of phosphatidylglycerol in vaginal pool samples in preterm premature rupture of membranes. Am J Obstet Gynecol 1993; 169: pp. 573-576

  29. 29. Garite T.J., Porto M., Carlson N.J., Rumney P.J., and Reimbold P.A.: The influence of elective amniotomy on fetal heart rate patterns and the course of labor in term patients: a randomized study. Am J Obstet Gynecol 1993; 168: pp. 1827-1832

  30. 30. Asrat T., Lewis D.F., Garite T.J., et al: Rate of recurrence of preterm premature rupture of membranes in consecutive pregnancies. Am J Obstet Gynecol 1991; 165: pp. 1111-1115

  31. 31. Toohey J.S., Lewis D.F., Harding J.A., et al: Does amniotic fluid index affect the accuracy of estimated fetal weight in preterm premature rupture of membranes? Am J Obstet Gynecol 1991; 165: pp. 1060-1062

  32. 32. Towers C.V., Kaminskas C.M., Garite T.J., Nageotte M.P., and Dorchester W.: Pulmonary injury associated with antepartum pyelonephritis: can patients at risk be identified? Am J Obstet Gynecol 1991; 164: pp. 974-980

  33. 33. Garite T.J.: Premature rupture of the membranes: the enigma of the obstetrician. Am J Obstet Gynecol 1985; 151: pp. 1001-1005

  34. 34. Freeman R.K., Dorchester W., Anderson G., and Garite T.J.: The significance of a previous stillbirth. Am J Obstet Gynecol 1985; 151: pp. 7-13

  35. 35. Yeast J.D., Garite T.J., and Dorchester W.: The risks of amniocentesis in the management of premature rupture of the membranes. Am J Obstet Gynecol 1984; 149: pp. 505-508

  36. 36. Garite T.J., Freeman R.K., Linzey E.M., Braly P.S., and Dorchester W.L.: Prospective randomized study of corticosteroids in the management of premature rupture of the membranes and the premature gestation. Am J Obstet Gynecol 1981; 141: pp. 508-515

  37. 37. Braly P.S., Freeman R.K., Garite T.J., Anderson G.G., and Dorchester W.: Incidence of premature delivery following the oxytocin challenge test. Am J Obstet Gynecol 1981; 141: pp. 5-8

  38. 38. Freeman R.K., Garite T.J., Mondanlou H., Dorchester W., Rommal C., and Devaney M.: Postdate pregnancy: utilization of contraction stress testing for primary fetal surveillance. Am J Obstet Gynecol 1981; 140: pp. 128-135

  39. 39. Garite T.J., Modaniou H.D., and Freeman R.K.: Sinusoidal fetal heart rate pattern. Am J Obstet Gynecol 1981; 139: pp. 226-230

  40. 40. Goldberg J.M., Khalifa E.A., Friedman C.I., and Kim M.H.: Improvement of in vitro fertilization and early embryo development in mice by coculture with human fallopian tube epithelium. Am J Obstet Gynecol 1991; 165: pp. 1802-1805

  41. 41. Douglas J.W., Miller F.A., and Kim M.H.: The effects of electric field-mediated transfer of nonpermeable molecules of meiosis, fertilization, and early embryo development. Am J Obstet Gynecol 1991; 165: pp. 1480-1486

  42. 42. Roh S.I., Batten B.E., Friedman C.I., and Kim M.H.: The effects of progesterone antagonist RU 486 on mouse oocyte maturation, ovulation, fertilization, and cleavage. Am J Obstet Gynecol 1988; 159: pp. 1584-1589

  43. 43. Park J.M., Ewing K., Miller F., Friedman C.I., and Kim M.H.: Effects of relaxin on the fertilization capacity of human spermatozoa. Am J Obstet Gynecol 1988; 158: pp. 974-979

  44. 44. Schmidt G.E., Sites C., Mansour R., Friedman C.I., and Kim M.H.: Embryo toxicity of clomiphene citrate on mouse embryos fertilized in vitro and in vivo. Am J Obstet Gynecol 1985; 153: pp. 679-684

  45. 45. Friedman C.I., Schmidt G.E., Kim M.H., and Powell J.: Serum testosterone concentrations in the evaluation of androgen-producing tumors. Am J Obstet Gynecol 1985; 153: pp. 44-49

  46. 46. Schweizer F.W., Kim M.H., and Malarkey W.B.: The diurnal variations of serum prolactin levels before and during pregnancy in normal and hyperprolactinemic patients. Am J Obstet Gynecol 1984; 149: pp. 367-371

  47. 47. Goodnough J.E., O’Dorisio T.M., Friedman C.I., and Kim M.H.: Vasoactive intestinal polypeptide in tissues of the human female reproductive tract. Am J Obstet Gynecol 1979; 134: pp. 579-580

  48. 48. Kim M.H., Rosenfield R.L., and Dupon C.: The effects of dexamethasone on plasma free androgens during the normal menstrual cycle. Am J Obstet Gynecol 1976; 126: pp. 982-986

  49. 49. Romero R., Garite T.J., Kim M.H., et al: Taking the . Am J Obstet Gynecol 2007; 196: pp. 1-2

  50. 50. Romero R., Garite T.J., Kim M.H., et al: The new . Am J Obstet Gynecol 2012; 206: pp. 364-373

Only gold members can continue reading. Log In or Register to continue

Related posts:

  1. CenteringPregnancy: an innovative approach to prenatal care delivery
  2. Influence of qualitative research on women’s health screening guidelines
  3. Factors associated with high-risk HPV positivity in a low-resource setting in sub-Saharan Africa
  4. Progress of labor in women induced with misoprostol vs the Foley catheter

Stay updated, free articles. Join our Telegram channel
Tags:
May 11, 2017 | Posted by in GYNECOLOGY | Comments Off on In appreciation of the leadership and stewardship of Drs Thomas J. Garite and Moon H. Kim

Full access? Get Clinical Tree
Get Clinical Tree app for offline access